Home › NDC Lookup › RxCUI directory › RxCUI 607044

Omega-3 acid ethyl esters (USP) 1000 MG Oral Capsule [Lovaza] — RxCUI 607044

RxNorm drug concept · Semantic branded drug
RxCUI 607044 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI607044
Official nameOmega-3 acid ethyl esters (USP) 1000 MG Oral Capsule [Lovaza]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asOmacor 1 GM Oral Capsule; Lovaza 1 GM Oral Capsule; Lovaza 1000 MG (at least 900 MG) Oral Capsule
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Omega-3-Acid Ethyl Esters: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This medication is specifically approved for adults with severely high triglyceride levels — 500 mg/dL or above. It's a prescription-strength omega-3 fatty acid, quite different fr...
  • What exactly is this medication for? My doctor said my triglycerides were very high.
  • Prescription omega-3-acid ethyl esters like Lovaza are not the same as over-the-counter fish oil. They contain standardized, concentrated amounts of EPA and DHA and have been teste...
  • Can I just take regular fish oil from the store instead?
📖 Read our full Omega-3-Acid Ethyl Esters guide →

🕸️ Concept Web — How Omega-3 acid ethyl esters (USP) 1000 MG Oral Cap... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Omega-3 acid ethyl esters (USP) 1000 MG Oral Capsule [Lovaza] RxCUI 607044

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Omega-3 acid ethyl esters (USP) 484348
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lovaza 278346
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Omega-3 acid ethyl esters (USP) Oral Capsule 809886
    • Omega-3 acid ethyl esters (USP) Oral Product 1161021
    • Omega-3 acid ethyl esters (USP) Pill 1161022
    • Omega-3 acid ethyl esters (USP) Oral Capsule [Lovaza] 809887
    • Lovaza Oral Product 1180928
    • Lovaza Pill 1180929
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Omega-3 acid ethyl esters (USP) 1000 MG Oral Capsule SCD · 577208
  • Omega-3 acid ethyl esters (USP) 1000 MG SCDC · 577206
  • Omega-3 acid ethyl esters (USP) Oral Capsule SCDF · 809886
  • Omega-3 acid ethyl esters (USP) Oral Product SCDG · 1161021
  • Omega-3 acid ethyl esters (USP) Pill SCDG · 1161022

Brand-Name Concepts

  • Omega-3 acid ethyl esters (USP) 1000 MG [Lovaza] SBDC · 607042
  • Omega-3 acid ethyl esters (USP) Oral Capsule [Lovaza] SBDF · 809887
  • Lovaza Oral Product SBDG · 1180928
  • Lovaza Pill SBDG · 1180929
  • Lovaza BN · 278346

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 607044 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80725-0420-12 120 CAPSULE in 1 BOTTLE, PLASTIC (80725-420-12) Lovaza Waylis Therapeutics LLC 2025-01-15
Observed labelers: Waylis Therapeutics LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.